CryoLife CE-marks tissue-engineered graft:
This article was originally published in Clinica
Executive Summary
CryoLife has CE-marked for sale in Europe its tissue-engineered vascular graft for dialysis access and peripheral vascular reconstruction. The SynerGraft model 100 graft is based on the Atlanta, Georgia's firm's SynerGraft technology, which centres around the removal of antigens from human and/or animal tissue leaving a collagen matrix that has the potential to be repopulated with the patient's own cells.